权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Determining Protective Features of Human Memory T-cells to Inform Mycobacterium tuberculosis Vaccine Development

确定人类记忆 T 细胞的保护特征，为结核分枝杆菌疫苗的开发提供信息

基本信息

批准号：
10682395
负责人：
Stephen Matthew Carpenter
金额：
$ 19.33万
依托单位：
CASE WESTERN RESERVE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-11 至 2027-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10682395
关键词：
Acceleration Adolescent Adult Animal Model Antigens Autologous Avidity Benchmarking Bioinformatics Biological Models Bronchoalveolar Lavage Fluid CD4 Positive T Lymphocytes Cell Separation Cell physiology Cells Cellular biology Cessation of life Chronic Clinical Clinical Investigator Award Clinical Research Coculture Techniques Collaborations Communicable Diseases Communities Cytoprotection Data Development Disease Environment Flow Cytometry Frequencies Funding Goals HIV Household Human Immune Immunologist Immunology Individual Infection Institution Learning Link Lung Lymphocyte Macrophage Mentors Mycobacterium tuberculosis Mycobacterium tuberculosis antigens Peptide/MHC Complex Peptides Persons Phenotype Physicians Positioning Attribute Predisposition Preparation Prevention Research Research Personnel Research Priority Severities Specificity System T cell response T memory cell T-Cell Antigen Receptor Specificity T-Cell Depletion T-Cell Receptor T-Lymphocyte Testing Training Translational Research Tuberculosis Tuberculosis Vaccines Uganda Universities Vaccine Design Vaccines Work antigen-specific T cells chronic infection cohort cytokine effector T cell experience experimental study fighting improved medical schools memory CD4 T lymphocyte mouse model prevent programs recruit risk stratification single cell analysis single-cell RNA sequencing skills transcriptomics vaccine candidate vaccine development

项目摘要

Project Summary / Abstract Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (Mtb), is a disease that kills 1.4 million people every year. There is no reliable vaccine to prevent TB, yet many latently-infected individuals are protected from progressing to active TB despite heavy Mtb exposure living in an endemic setting. CD4+ T cells are critical for host protection against TB as they interact directly with Mtb-infected cells, secrete cytokines and cytolytic molecules, and recruit or augment other immune cells. However, the candidate and others find that not all T cells specific for Mtb antigens are able to recognize Mtb-infected macrophages, the niche cell for Mtb. A critical unmet need for vaccine development is to define the antigen specificities and functions of T cells that can recognize infected macrophages and prevent progression to active TB. In Aim 1, the candidate uses autologous ex vivo co-culture and T cell antigen receptor (TCR) sequencing to determine the proportion, antigen specificities and functions of memory CD4+ T cells that recognize Mtb-infected macrophages. In Aim 2, the candidate expands on this system to compare the repertoires of memory CD4 T cells that respond to infected macrophages among two groups of individuals who live in a setting endemic for TB yet differ in their susceptibility to active disease. Using single-cell transcriptomics, the candidate compares the functions and TCR repertoires of Mtb- specific memory CD4+ T cells isolated from exposed individuals who do not develop active TB (“stable” latent Mtb infection) vs. individuals who will later progress to active TB (“pre-TB” progressors). Results from this project will define key features of protective memory CD4+ T cells that are linked to the prevention of active TB, providing benchmarks for vaccine development and improvement of TB risk stratification. This 5-year K08 program provides mentoring, training in human immunology, translational research and single-cell transcriptomics for Dr. Stephen Carpenter, a T cell immunologist and infectious disease physician at Case Western Reserve University (CWRU). The institutional environment at CWRU combines an established TB research unit, BSL-3 flow cytometry, cell sorting, single-cell RNA sequencing, and expertise in bioinformatics together with a premier graduate program for scientific interaction and courses. The longstanding Uganda- CWRU Research Collaboration for TB enables clinical and translational work in a TB endemic setting. The candidate is establishing a lab with the long-term goals of understanding the defining features of protective memory T cell responses to Mtb. He has recruited mentors with substantial expertise in translational TB research, T cell biology and single-cell transcriptomics, including Drs. Henry Boom and Mark Cameron at CWRU, and Dr. Sam Behar (UMass Medical School). Completion of this K08 project will transition the candidate into an independent investigator, positioning his research program to use powerful single-cell immune profiling approaches to track and study antigen-specific human memory T cells.

项目总结/摘要结核病（TB）是由结核分枝杆菌（Mtb）感染引起的疾病，每年有100万人。没有可靠的疫苗来预防结核病，但许多潜伏感染者尽管生活在地方性环境中的Mtb暴露严重，但仍能防止进展为活动性结核病。cd 4 + T细胞对于宿主保护免受结核病感染至关重要，因为它们直接与结核分枝杆菌感染的细胞相互作用，分泌细胞因子，细胞溶解分子，并募集或增加其他免疫细胞。然而，候选人和其他人发现，所有对Mtb抗原特异的T细胞都能够识别Mtb感染的巨噬细胞，即Mtb的小生境细胞。一疫苗开发的关键未满足的需求是确定T细胞的抗原特异性和功能，识别受感染的巨噬细胞并防止进展为活动性结核病。在目标1中，候选人使用自体离体共培养和T细胞抗原受体（TCR）测序，以确定比例、抗原特异性以及识别Mtb感染的巨噬细胞的记忆性CD 4 + T细胞的功能。在目标2中，候选人扩展了这一系统，比较了记忆性CD 4 T细胞对感染巨噬细胞的反应在两组生活在结核病流行环境中但对活性结核病易感性不同的个体中，疾病使用单细胞转录组学，候选人比较了Mtb的功能和TCR库，从未发展为活动性TB的暴露个体分离的特异性记忆性CD 4 + T细胞（“稳定”潜伏性结核分枝杆菌感染）与后来进展为活动性结核的个体（“前结核”进展者）。本项目的成果将定义与预防活动性结核病有关的保护性记忆CD 4 + T细胞的关键特征，疫苗开发和改进结核病风险分层的基准。这个为期5年的K 08计划提供指导，在人类免疫学，转化研究和斯蒂芬·卡彭特博士，一位T细胞免疫学家和传染病医生，凯斯西储大学Case Western Reserve University（CWRU）CWRU的制度环境结合了既定的结核病研究单位、BSL-3流式细胞术、细胞分选、单细胞RNA测序和生物信息学专业知识以及一流的科学互动和课程研究生课程。乌干达历史悠久- CWRU结核病研究合作使结核病流行环境中的临床和转化工作成为可能。的候选人正在建立一个实验室，其长期目标是了解保护性记忆T细胞对结核分枝杆菌的应答他招募了在转化型结核病研究方面具有丰富专业知识的导师， T细胞生物学和单细胞转录组学，包括博士亨利布姆和马克卡梅隆在CWRU，博士。萨姆·贝哈尔（马萨诸塞大学医学院）。K 08项目的完成将使候选人转变为独立调查员，定位他的研究计划，使用强大的单细胞免疫分析追踪和研究抗原特异性人类记忆T细胞的方法。